miR122-controlled all-in-one nanoplatform for in situ theranostic of drug-induced liver injury by visualization imaging guided on-demand drug release
Drug-induced liver injury (DILI) is a challenging clinical problem with respect to both diagnosis and management. As a newly emerging biomarker of liver injury, miR122 shows great potential in early and sensitive in situ detection of DILI. Glycyrrhetinic acid (GA) possesses desirable therapeutic eff...
Guardado en:
Autores principales: | Lingchang Meng, Qiaolei Wang, Lai Wang, Zhen Zhao, Gui-Zhong Xin, Zuguo Zheng, Ping Zhou, Ping Li, Yan Jiang, Hui-Jun Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f5f733cc6914f77b87c7c4ef60d5273 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Paclitaxel/IR1061-Co-Loaded Protein Nanoparticle for Tumor-Targeted and pH/NIR-II-Triggered Synergistic Photothermal-Chemotherapy
por: He L, et al.
Publicado: (2020) -
Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities
por: Ruman U, et al.
Publicado: (2020) -
Dexamethasone release from photopolymerised PEGDA700 for cochlea drug delivery
por: Thomas Eickner, et al.
Publicado: (2020) -
Targeted acetylcholinesterase-responsive drug carriers with long duration of drug action and reduced hepatotoxicity
por: Lin Y, et al.
Publicado: (2019) -
A Highly Efficient One-for-All Nanodroplet for Ultrasound Imaging-Guided and Cavitation-Enhanced Photothermal Therapy
por: Qin D, et al.
Publicado: (2021)